Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response
The ability to predict response to neoadjuvant chemotherapy for women diagnosed with breast cancer, either before or early on in treatment, is critical to judicious patient selection and tailoring the treatment regimen. In this paper, we investigate the role of contrast agent kinetic heterogeneity f...
Main Authors: | Ahmed Ashraf, Bilwaj Gaonkar, Carolyn Mies, Angela DeMichele, Mark Rosen, Christos Davatzikos, Despina Kontos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-06-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523315000212 |
Similar Items
-
Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration
by: Nariman Jahani, et al.
Published: (2019-08-01) -
The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
by: Yanan Lu, et al.
Published: (2019-10-01) -
3T DCE-MRI Radiomics Improves Predictive Models of Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Stefania Montemezzi, et al.
Published: (2021-04-01) -
Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI
by: Alina Tudorica, et al.
Published: (2016-02-01) -
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
by: Nathaniel M. Braman, et al.
Published: (2017-05-01)